View in EDS

Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.

Saved in:
Bibliographic Details
Title: Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.
Authors: Klasfeld SJ; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA., Knutson KA; Clinical Omics and Biomarker Statistics, Pfizer Research and Development, Cambridge, MA 02139, USA., Miller MR; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA., Fauman EB; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA., Berghout J; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA., Moccia R; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA; Machine Learning and Computational Sciences, Pfizer Research and Development, Cambridge, MA 02139, USA. Electronic address: robert.moccia@pfizer.com., Kim HI; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA. Electronic address: hyein.kim@pfizer.com.
Source: HGG advances [HGG Adv] 2025 Jul 10; Vol. 6 (3), pp. 100460. Date of Electronic Publication: 2025 May 22.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101772885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-2477 (Electronic) Linking ISSN: 26662477 NLM ISO Abbreviation: HGG Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40411145
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Klasfeld+SJ%22">Klasfeld SJ</searchLink>; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Knutson+KA%22">Knutson KA</searchLink>; Clinical Omics and Biomarker Statistics, Pfizer Research and Development, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Miller+MR%22">Miller MR</searchLink>; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Fauman+EB%22">Fauman EB</searchLink>; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Berghout+J%22">Berghout J</searchLink>; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Moccia+R%22">Moccia R</searchLink>; Rare Disease Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA; Machine Learning and Computational Sciences, Pfizer Research and Development, Cambridge, MA 02139, USA. Electronic address: robert.moccia@pfizer.com.<br /><searchLink fieldCode="AU" term="%22Kim+HI%22">Kim HI</searchLink>; Internal Medicine Research Unit, Pfizer Research and Development, Cambridge, MA 02139, USA. Electronic address: hyein.kim@pfizer.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101772885%22">HGG advances</searchLink> [HGG Adv] 2025 Jul 10; Vol. 6 (3), pp. 100460. <i>Date of Electronic Publication: </i>2025 May 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101772885 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-2477 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226662477%22">26662477 </searchLink><i>NLM ISO Abbreviation: </i>HGG Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40411145
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.xhgg.2025.100460
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100460
    Titles:
      – TitleFull: Common genetic modifiers influence cardiomyopathy susceptibility among the carriers of rare pathogenic variants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Klasfeld SJ
      – PersonEntity:
          Name:
            NameFull: Knutson KA
      – PersonEntity:
          Name:
            NameFull: Miller MR
      – PersonEntity:
          Name:
            NameFull: Fauman EB
      – PersonEntity:
          Name:
            NameFull: Berghout J
      – PersonEntity:
          Name:
            NameFull: Moccia R
      – PersonEntity:
          Name:
            NameFull: Kim HI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 07
              Text: 2025 Jul 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2666-2477
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: HGG advances
              Type: main
ResultId 1